Plx Pharma Inc (PLXP) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Sep 30 2022 to Sep 30 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Plx Pharma Inc   (NASDAQ: PLXP)


Plx Pharma Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Plx Pharma Inc's ROI in the third quarter of 2022?
Plx Pharma Inc recorded a cumulative net loss of $-25 million during 12 months ending in the third quarter of 2022, resulting in a negative return on investment (ROI) of -61.5%.

Within the Healthcare sector 767 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2022 from 0 to 4640.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Investment Change TTM -34.1 % 32.5 % 195.17 % 1254.57 % 1124.23 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 24 33 45 62 82
Return On Investment (TTM) -61.5 % -69.23 % -64.11 % -58.09 % -90.78 %
PLXP's Overall Ranking # 4640 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -25.85 % -17.37 % -10.29 % 19.87 % 49.1 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -25 -39 -43 -44 -57

PLXP Company Profile >> Back to PLXP Roi Comparisons >> See Annual PLXP Return On Investment



Return On Investment PLXP's Ranking
Within: No.
Industry # 347
Sector # 768
Overall # 4640

Return On Investment Statistics
High Average Low
94.94 %
-38.67 %
-177.23 %
(Jun 30 2020)   (Dec 31 2020)







Financial Statements
Plx Pharma Inc's III. Quarter Investments $ 24 Millions PLXP's Balance sheet
Plx Pharma Inc's III. Quarter Income $ -8 Millions Quarterly PLXP's Income Statement
PLXP's Income by Division See PLXP's Income by Division


PLXP Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017
Total Investments in Millions 62 13 11 13 27
Y / Y Investment Growth 396.43 % 15.73 % -18.71 % -50.47 % 79.99 %
Net Income in Millions -44 -13 -7 1 -15
Y / Y Net Income Growth - - - - -
Annual Return On Investment -69.95 % -107.31 % -62.23 % 6.72 % -56.96 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PLXP's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PLXP's Competitors
Subscribers only: Roi for Plx Pharma Inc's Suppliers
Subscribers only: Return On Investment for PLXP's Customers

Other Ratios
PLXP's Roa PLXP's Inventory Turnover Ratio PLXP's Growth Rates PLXP's Dividend Statistics
PLXP's Profitability Ratios PLXP's Asset Turnover Ratio PLXP's Dividend Growth
PLXP's Roe PLXP's Valuation Ratios PLXP's Financial Strength Ratios PLXP's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2022, within Healthcare Sector ROI

Date modified: 2026-08-29T17:26:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.